ADEYOYIN ESAKA: Open Payments
NPI 1003270927 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 11 payments from 8 companies in 2025. Trend: 2023 $334 · 2024 $327 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $124 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| PFIZER INC. | 1 | $120 |
| Amgen Inc. | 1 | $92 |
| Kestra Medical Technology Services, Inc. | 4 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $76 |
| GlaxoSmithKline, LLC. | 1 | $69 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $13 |
Products named: Ozempic, RECORLEV, VYNDAQEL, REPATHA, Assure WCD, JARDIANCE, NUCALA, LifeVest.
Industry payments across DE — which companies pay providers there.
